Você procurou por: l skal (Dinamarquês - Inglês)

de to måledistancer l skal have samme længde og være praktisk talt parallelle.
the two measuring bases l must be equal in length and virtually parallel to each other.

længden l° skal omtrent svare til opacimeterets formodede effektive længde.
this length l° must be close to the supposed effective length of the opacimeter.

køretøjer i klasse l skal overholde en række forskrifter, som forefindes i forskellige direktiver.
l-category vehicles have to comply with a series of requirements found in a number of separate directives.

hvis dette overstiger 2,5 g/l , skal man udskille det overskydende aktiverede slam.
if it is more than 2 75 g/l, the excess activated sludge must be discarded.

er den laveste toksicitet ≤ 10 mg/l, skal der forelægges et prøvningsresultat for let bionedbrydelighed.
if the lowest toxicity is ≤ 10 mg/l a test result for ready biodegradability must be given.

den allerede etablerede ebri­fortegnelse (l^ ) skal bringes helt up­to­date og indpasses i medrep.
it is intended to upda­te the existing ebri inventory (1^) and incorporate it in the medrep inventory.

hvis leukocyttallet stiger til > 70 x 109/ l, skal filgrastim seponeres, eller dosis nedsættes.
filgrastim administration should be discontinued or its posology should be reduced if the leukocyte counts rise to > 70 x 109/ l.

15 absolutte neutrofillocyttal 1, 3 x 103/l) , skal behandlingen med cellcept måske afbrydes eller stoppes.
if neutropenia develops (absolute neutrophil count 1.3 x 103/µl) it may be appropriate to interrupt or discontinue cellcept.

et vedvarende hæmoglobinniveau, som er højere end 12 g/dl (7, 5 mmol/l) skal undgås.
a sustained haemoglobin level of greater than 12 g/dl (7.5 mmol/l) should be avoided; guidance for appropriate dose adjustment for when haemoglobin values exceeding 12 g/dl (7.5 mmol/l) are observed are described below.

indhold på under 20 mg/l skal verificeres ved identifikation ved tyndtlagskromatografi (følsomhed: 1 mg/l).
thin layer chromatography is used for confirmation of levels (1 mg/l) less than 20 mg/l.

hb mellem 10 og 12 g/ dl (6, 2 - 7, 5 mmol/ l) skal der eventuelt dosisjusteres.
hb between 10 and 12 g/ dl (6.2 - 7.5 mmol/ l).

hb mellem 9, 5 og 11 g/dl (5, 9 -6, 8 mmol/l) skal der eventuelt dosisjusteres.
dose adjustment in order to maintain haemoglobin values at the desired level:

ved opnåelse af ir, dokumenteret ved to konsekutive cd3+-celletællinger ≥ 100/l, skal behandlingen med zalmoxis stoppes.
in case of ir achievement, documented by two consecutive cd3+ cell counts ≥ 100/µl, zalmoxis treatment has to be stopped.